ClinHope Officially Establishes Hong Kong Branch to Strengthen Asia-Pacific Market Presence

ClinHope announced the official establishment of its Hong Kong branch on Sept. 3, 2026, marking an additional step in expanding its services in the Asia-Pacific market after operations in Taiwan and the United States. The company said the move supports biotech, pharmaceutical, and medical device clients with professional services spanning clinical research, regulatory affairs, and quality management. In a statement, ClinHope positioned Hong Kong as a highly international hub connecting Asia with global markets, and said it will use the location as a regional base while integrating resources from Taiwan, the U.S., and Hong Kong to deliver cross-regional offerings. CEO Abby Chang called the branch a milestone in the company’s globalization journey.